Isto Biologics:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Isto Biologics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6460
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Isto Biologics is an orthobiologics company which manufactures and develops biological products to treat orthopedic and spine disorders. The company offers solutions in cell therapy, bone healing and regeneration that harness cells and proteins naturally found in human biology which support the regrowth of musculoskeletal tissues, including cartilage, bone, tendons, and ligaments. Its products portfolio includes InQu, a bone graft extender and substitute that is a biosynthetic bone graft; Magellan, an autologous platelet separator; and CellPoint, a concentrated bone marrow aspirate system, and Influx, a trabecular bone graft. Isto Biologics’ patented biosynthetic platform is utilized in the InQu bone graft which is composed of synthetic poly (lactide-co-glycolide) (PLGA) combined with hyaluronic acid (HyA). The company is an integration between Isto Technologies, Inc and Arteriocyte Medical Systems, Inc. Isto Biologics is headquartered in St. Louis, Missouri, the US.

Isto Biologics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Isto Biologics , Medical Equipment, Deal Details 10
Venture Financing 10
Isto Technologies Raises US$8 Million In Venture Financing 10
Isto Technologies Raises US$2 Million In Venture Financing 11
Private Equity 12
Thompson Street Capital Partners Acquires Commercial Operations of ISTO Tech 12
Acquisition 13
Isto Acquires Arteriocyte Medical Systems 13
Isto Biologics – Key Competitors 14
Isto Biologics – Key Employees 15
Isto Biologics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Isto Biologics , Medical Equipment, Key Facts 2
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Deals By Market, 2012 to YTD 2018 8
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Isto Technologies Raises US$8 Million In Venture Financing 10
Isto Technologies Raises US$2 Million In Venture Financing 11
Thompson Street Capital Partners Acquires Commercial Operations of ISTO Tech 12
Isto Acquires Arteriocyte Medical Systems 13
Isto Biologics , Key Competitors 14
Isto Biologics , Key Employees 15
Isto Biologics , Other Locations 16
Isto Biologics , Subsidiaries 16

List of Figures
Isto Biologics , Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Isto Biologics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Laboratories (ABT)-製薬・医療分野:企業M&A・提携分析
    Summary Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; me …
  • Heiwa Real Estate Co Ltd:企業の戦略・SWOT・財務情報
    Heiwa Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Heiwa Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Frontier Communications Corporation:企業の戦略・SWOT・財務情報
    Frontier Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary Frontier Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • R Pharm-製薬・医療分野:企業M&A・提携分析
    Summary R Pharm is a pharmaceutical company that offers drug development and manufacturing. The company offers finished dosage forms, active pharmaceutical ingredients (api) and biotechnological substances. It provides products in therapeutic areas of oncology, hematology, immune diseases, antibioti …
  • EMIS Group plc (EMIS):企業の財務・戦略的SWOT分析
    Summary EMIS Group Plc (EMIS), formerly Egton Medical Information Systems Ltd, is a provider of information technology and related services. The company provides electronic patient record systems and software solutions such as EMIS web, used for clinical services; EMIS IQ for data extraction; and sy …
  • Lantern Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lantern Pharma Inc (Lantern Pharma) is a clinical stage pharmaceutical company that discovers and develops therapies for various cancer types. The company’s pipeline products Irofulven-1 and Irofulven-2 are non-hormone, non-chemotherapy, next-generation DNA damage repair inhibitors. Its othe …
  • Biosense Webster Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Entellus Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Entellus Medical Inc (Entellus Medical), a subsidiary of Stryker Corp, is a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation system, …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • Laricina Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Laricina Energy Ltd (Laricina Energy) is an upstream oil and gas company that explores, produces and develops oil sand properties in Western Canada. The company offers development of underground bitumen deposits in sand and carbonate formations. It operates Germain property and Saleski prope …
  • KnowBe4 Inc:企業の戦略的SWOT分析
    KnowBe4 Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ReShape Lifesciences Inc (RSLS)-医療機器分野:企業M&A・提携分析
    Summary ReShape Lifesciences Inc(ReShape Lifesciences) formerly known as EnteroMedics Inc, is a medical equipment provider that offers therapeutic and neuroregulator systems. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops VBLOC therapy …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Manhattan Associates Inc (MANH):企業の財務・戦略的SWOT分析
    Manhattan Associates Inc (MANH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • United Cooperative Services, Inc.:企業の戦略的SWOT分析
    United Cooperative Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • TransAlta Corporation:企業の戦略・SWOT・財務分析
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alimera Sciences Inc (ALIM):企業の財務・戦略的SWOT分析
    Alimera Sciences Inc (ALIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析
    Summary Cyclo Therapeutics Inc (Cyclo Therapeutics), formerly CTD Holdings Inc, is a biotechnology company that develops and manufactures cyclodextrin-based drugs. It is investigating Trappsol Cyclo, an orphan drug against Niemann-Pick disease type C and Alzheimer’s disease. The company also develop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆